Back to Search
Start Over
Successful treatment of KPC-MDR septic shock with ceftazidime-avibactam in a pediatric critically ill patient
- Source :
- IDCases, IDCases, Vol 18, Iss, Pp-(2019)
- Publication Year :
- 2019
- Publisher :
- Elsevier, 2019.
-
Abstract
- Ceftazidime–avibactam is a combination agent consisting of the β-lactamase inhibitor avibactam and the broad-spectrum cephalosporin ceftazidime. There are no published case reports or studies evaluating the use of CAZ-AVI in pediatric critically ill patients. We report a case of a successful treatment of septic shock due to Klebsiella pneumonie (KP) in a 14-years-old boy (body weight 50 kg) admitted in intensive care unit (ICU). Keywords: Ceftazidime-avibactam, Septic shock, Pediatric critically ill patient
- Subjects :
- 0301 basic medicine
medicine.medical_specialty
Klebsiella
medicine.drug_class
Avibactam
030106 microbiology
Cephalosporin
Ceftazidime
Pediatric critically ill patient
Infectious and parasitic diseases
RC109-216
Article
law.invention
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
law
Septic shock
medicine
030212 general & internal medicine
Intensive care medicine
biology
Critically ill
business.industry
Ceftazidime-avibactam
biology.organism_classification
medicine.disease
Ceftazidime/avibactam
Intensive care unit
Infectious Diseases
chemistry
business
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 22142509
- Volume :
- 18
- Database :
- OpenAIRE
- Journal :
- IDCases
- Accession number :
- edsair.doi.dedup.....7755b2063c6c676aa2cc62a24b9db5cd